We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Oral anticancer therapies, as well as treatments for multiple sclerosis and arthritis, will be covered under the Medicare Part B replacement drug demonstration project now under way, according to HHS Secretary Tommy Thompson.
Unless the pharmaceutical industry takes steps to reduce the global price disparity for prescription drugs — including cutting prices in the U.S. — the importation of Rx drugs and price controls are inevitable, according to a new report from Ernst & Young.
The AARP has said it will endorse the drug importation bill sponsored by Sen. Byron Dorgan (D-N.D.) in large part because it contains a provision that would prevent pharmaceutical companies from choking off the supply of drugs manufactured in the U.S. to providers abroad.
Amid indications that not as many seniors as expected have signed up for the Medicare discount drug cards, HHS yesterday announced it is making an additional $4.6 million available to help low-income beneficiaries learn about the program and how to enroll.
Although only two states so far allow psychologists with training in psychopharmacology to prescribe mental health drugs — making them attractive pharma marketing targets — the American Psychological Association (APA) is trying to “get ahead of the curve” in developing professional standards for relationships with drugmakers, according to a senior APA official.
U.S. drugmakers — especially brand companies — would be able to use several options available to them to minimize the effects of changes in prescription drug importation policy on U.S. pharmaceutical prices, including gaining FDA and foreign-government cooperation in limiting the trade practice, according to a report from the Congressional Budget Office (CBO).
State prescription drug monitoring programs can help prevent diversion of pharmaceuticals for illegal uses, but they may also reduce the number of prescriptions written for targeted drugs, according to a new report from the U.S. General Accounting Office (GAO).
In an effort to squelch the FDA’s criticism of Minnesota’s Rx drug reimportation website, Gov. Tim Pawlenty has invited the agency to inspect the operation and test the safety and validity of the state’s approach to providing U.S. residents with information on obtaining pharmaceuticals from Canada.
The FDA’s efforts to close a loophole in enforcement actions on marketed unapproved drugs have pitted one drugmaker that argues the loophole punishes firms that apply for a new drug application (NDA) against another company that says closing the loophole will limit competition and drive up prices for the drugs.
A 10-year-old lawsuit against Wyeth being considered for possible review by the U.S. Supreme Court could set a legal precedent for patent law in the United States.